Soluble ACE2 as a Risk or Prognostic Factor in COVID-19 Patients: A Cross-sectional Study

Authors:

Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus. The first known receptor for this virus in the human body is angiotensin-converting enzyme 2 (ACE2), the same receptor for the SARS virus. Methods: A total of 38 hospitalized adult (18 years) patients with laboratory or ...
All Related Versions

This publication has 21 references indexed in Scilit: